Viewing Study NCT00789958


Ignite Creation Date: 2025-12-25 @ 12:24 AM
Ignite Modification Date: 2026-01-31 @ 7:31 AM
Study NCT ID: NCT00789958
Status: COMPLETED
Last Update Posted: 2018-04-09
First Post: 2008-11-12
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct
Sponsor: SWOG Cancer Research Network
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Extrahepatic Bile Duct Cancer View
None Gallbladder Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None cholangiocarcinoma of the extrahepatic bile duct View
None cholangiocarcinoma of the gallbladder View
None localized extrahepatic bile duct cancer View
None localized gallbladder cancer View
None unresectable extrahepatic bile duct cancer View
None unresectable gallbladder cancer View
None metastatic extrahepatic bile duct cancer View
None metastatic gallbladder cancer View